| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |